Revive Therapeutics (OTC:RVVTF) said today that it inked a research agreement with the University of Wisconsin-Madison to develop a drug delivery technology for cannibinoids. The research program, led by Jess Reed, is slated to evaluate chitosan-tannin composite biomaterial as a delivery mechanism for cannabinoids. Therapeutic biomaterials made from a composite of chitosan and tannin include […]
Pain Management
Tactile Systems launches Flexitouch lymphedema device
Tactile Systems Technology said today it launched its Flexitouch device designed to treat lymphedema of the head and neck, touting it as the 1st and only pneumatic compression therapy approved for the condition. The Flexitouch device is designed to use pneumatic compression to stimulate the lymphatic system to deliver non-invasive, self-delivered therapy for lymphedema, which is […]
Liquidia touts Phase I data for sustained-release post-surgical pain reliever
Liquidia Technologies touted initial data from its LIQ865 Phase I trial, which evaluated its sustained-delivery formulation of bupivacaine for post-surgical pain relief. The trial was the 1st evaluation of the company’s formulation in humans. Researchers assessed the safety, pharmacokinetic profile and pharmacodynamic response of a single-ascending dose in healthy adult males. Get the full story […]
Anika touts Phase III data for Cingal knee therapy
Anika Therapeutics (NSDQ:ANIK) touted data today from a Phase III trial for its Cingal hyaluronic acid-corticosteroid combination viscosupplement as a treatment for osteoarthritis-related knee pain. The data showed that treatment with Cingal yielded better immediate and short-term pain relief compared to hyaluronic acid alone and better pain and stiffness relief through 26 weeks compared to saline. […]
Myoscience wins FDA nod for Iovera knee osteoarthritis device
Myoscience said today it won FDA 510(k) clearance for its Iovera device designed to relieve pain and symptoms associated with knee osteoarthritis. The Fremont, Calif.-based company’s Iovera technology is a non-opioid and non-systemic treatment designed to block pain signals from the peripheral nerves. Myoscience said the Iovera treatment uses the body’s natural response to cold […]
Aptar Pharma’s nasal spray compliance device wins EMA nod
Aptar Pharma said today that the European Medicines Agency approved its electronic nasal lockout device, e-Lockout. The device is the 1st and only fully-integrated electronic nasal drug delivery device to be approved by a European regulatory authority, according to the company. The e-Lockout device is a part of a multi-year development deal with Takeda Pharmaceuticals […]
‘Growing pains’ push Nevro shares down on Q1 sales, earnings misses
Nevro (NYSE:NVRO) shares were under pressure in pre-market trading today after the medical device maker missed expectations for its 1st-quarter sales and earnings. Redwood City, Calif.-based Nevro, which makes the Senza spinal cord stimulation device, posted losses of -$14.7 million, or -50¢ per share, on sales of $68.4 million for the 3 months ended March 31. That […]
FDA clears Halyard’s Coolief RF device for treating OA pain
Halyard Health (NYSE:HYH) said today it won FDA clearance for its Coolief cooled radiofrequency thermal system designed for treating moderate to severe chronic osteoarthritis knee pain The Alpharetta, Ga.-based company claims that the Coolief is the 1st and only RF treatment to be cleared by the FDA for relieving OA pain. “I see many patients who suffer with chronic […]
Medtronic updates 2011 warning on Synchromed II implantable drug pumps
Medtronic (NYSE:MDT) this month updated physicians on a warning it 1st issued in July 2011 about the batteries in its SynchroMed II implantable drug infusion pump. The pumps are used primarily to treat chronic pain or severe spinal or cerebral spasticity. The issue, 1st reported in July 2009, relates to the formation of a filmy substance within the […]
FDA clears ElectroCore’s GammaCore cluster headache treatment
Neuroscience tech developer ElectroCore said today it won FDA clearance for its GammaCore non-invasive vagus nerve stimulator designed to treat pain associated with episodic cluster headaches. The GammaCore device is designed to transmit a mild electrical stimulation to the vagus nerve through the skin to reduce pain, the Basking Ridge, N.J.-based company said. The device is […]
AcelRx touts data from Dsuvia pain relief trials
AcelRx Pharmaceuticals (NSDQ:ACRX) touted efficacy and safety data today for its pain reliever, Dsuvia. The company’s lead drug candidate is composed of 30 sufentanil tablets delivered sublingually using a disposable, pre-filled single-dose applicator. Dsuvia is investigational and not approved in any country. The 4 late-phase studies enrolled 480 patients total. In 2 randomized studies, enrolled patients underwent bunionectomy […]